COMMUNIQUÉS West-GlobeNewswire

Le chef de la direction financière assistera au Cantor Fitzgerald Global Healthcare Conference à New York

30/09/2019 - 18:18

MONTRÉAL, 30 sept. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que Philippe Dubuc, vice-président senior et chef de la direction financière, fera une [...]

Cronos Group Announces Appointment of Jody Begley to Board of Directors

30/09/2019 - 18:01

TORONTO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that, in connection with its investment in the Company, Altria Group, Inc. (“ [...]

Molina Healthcare Announces Third Quarter 2019 Earnings Release and Conference Call Dates

30/09/2019 - 18:00

Long Beach, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the third quarter ended September 30, 2019. Molina Healthcare will [...]

CV Sciences Applauds House Passage of the SAFE Banking Act of 2019

30/09/2019 - 17:59

The SAFE Banking Act Provides the Cannabis Industry Access to Banking and Financial Services SAN DIEGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we [...]

Resignation of JSC Olainfarm member of the Management Board

30/09/2019 - 17:51

JSC Olainfarm has received the letter of resignation from Veranika Dubitskaya whereby she steps down from her duties as a member of the Management Board as of 30 September 2019. JSC Olainfarm Management Board continues [...]

First Substantial Customer: Tennessee Oncology Internalizes Precipio’s HemeScreen™

30/09/2019 - 17:10

Following completion of a successful validation testing, laboratory set to launch assay NEW HAVEN, Conn., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that [...]

Nature Biotechnology Study Reveals That Tempus’ xT Platform Increases Cancer Patients’ Personalized Therapeutic Opportunities

30/09/2019 - 17:00

CHICAGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today published a study in Nature [...]

Total number of shares and voting rights in Zealand Pharma at September 30, 2019

30/09/2019 - 17:00

Company announcement – No. 36 / 2019 Total number of shares and voting rights in Zealand Pharma at September 30, 2019 Copenhagen, September 30, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78 [...]

New Report Sheds Light on Japan’s Digital Healthcare Economy

30/09/2019 - 16:38

Commonalities between the UK and Japan exist, and a new whitepaper gives insights into the areas of data, digitisation and collaboration LONDON, Sept. 30, 2019 (GLOBE NEWSWIRE) -- HIMSS, a global advisor and thought [...]

Data from Agios’ Phase 3 ClarIDHy Trial of TIBSOVO® Demonstrates Significant Improvement in Progression Free Survival (PFS) Compared to Placebo in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients

30/09/2019 - 16:30

– TIBSOVO ® Reduced the Risk of Disease Progression or Death by 63% (HR=0.37, p<0.001); Median PFS for Patients Randomized to TIBSOVO ® was 2.7 months Compared to 1.4 Months with Placebo – – TIBSOVO ® Patients Had 6- [...]

Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer

30/09/2019 - 16:30

New England Journal of Medicine publishes data showing improved survival with Jevtana ® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer CARD is a treatment [...]

Sanofi : Le New England Journal of Medicine publie des données montrant que Jevtana® (cabazitaxel) améliore la survie comparativement à un agent ciblant le récepteur des androgènes de deuxième ligne dans le traitement du cancer de la prosta

30/09/2019 - 16:30

Le New England Journal of Medicine publie des données montrant que Jevtana ® (cabazitaxel) améliore la survie comparativement à un agent ciblant le récepteur des androgènes de deuxième ligne dans le traitement du cancer [...]

Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer

30/09/2019 - 16:30

IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in people with previously untreated advanced bladder cancer Tecentriq combination reduced the risk of disease worsening or death ( [...]

Novo Nordisk A/S – Share repurchase programme

30/09/2019 - 16:26

Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 30 September 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the [...]

Generex Biotechnology Subsidiary Olaregen Therapeutix Signs National Sales & Distribution Agreement With AvKare Medical to Distribute Excellagen® Throughout the VA Hospital System

30/09/2019 - 15:49

AvKare Medical, a Service-Disabled Veteran-Owned Small Business (SDVOSB), is a leading distributor of healthcare products Nationwide distribution and direct sales force to more than 170 VA medical centers and government [...]

Innovation Pharmaceuticals Engages Locust Walk, A Global Life Sciences Transaction Firm

30/09/2019 - 15:30

Objective to further unlock market potential of pipeline and determine the appropriate path forward to enhance shareholder value Locust Walk is a global life sciences transaction firm with exceptional strategic insights [...]

Digipath to Acquire Cannabis Technology Firm VSSL Enterprises Ltd.

30/09/2019 - 15:30

VSSL CEO Kyle Remenda Appointed Digipath Chief Executive Officer LAS VEGAS, NV, Sept. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Digipath, Inc. (OTCQB: DIGP) , is pleased to announce it has entered into a binding [...]

Albireo Announces Presentations at NASPGHAN 2019 Annual Meeting

30/09/2019 - 15:23

Presentations highlight data on odevixibat’s minimal systemic exposure and Albireo’s proprietary pruritus assessment tools BOSTON, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage [...]

CK Hutchison prices offering of Chi-Med share capital enabling deconsolidation and confirms its intention to hold Chi-Med as a strategic investment for the long term

30/09/2019 - 15:12

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION LONDON, Sept. 30, 2019 (GLOBE [...]